Enfuvirtide for prophylaxis against HIV infection.
Cuzin
Lise
L
Alvarez
Muriel
M
D003362:Cost-Benefit Analysis; D004351:Drug Resistance; D000077560:Enfuvirtide; D015700:HIV Envelope Protein gp41 / Q000191:economics / Q000627:therapeutic use*; D023581:HIV Fusion Inhibitors / Q000191:economics / Q000627:therapeutic use*; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D015497:HIV-1; D006801:Humans; D010446:Peptide Fragments / Q000191:economics / Q000627:therapeutic use*
D015700:HIV Envelope Protein gp41; D023581:HIV Fusion Inhibitors; D010446:Peptide Fragments; D000077560:Enfuvirtide